Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Beginning Cash Balance (2019 - 2024)

Immatics (IMTX) posted Beginning Cash Balance of $249.0 million for Q1 2025, up 4.93% sequentially from $237.3 million in Q1 2024, and up 4.93% YoY from $237.3 million in Q1 2024.

Analysis

Immatics (IMTX) Beginning Cash Balance (2019 - 2024) Analysis & Trends

Immatics has reported Beginning Cash Balance for 5 years, with the latest figure at $249.0 million in Q1 2025.

  • Quarterly Beginning Cash Balance rose 4.93% year-over-year to $249.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $486.4 million (up 25.81% YoY) and the FY2021 annual result came in at $245.6 million, up 108.12% from the prior year.
  • Beginning Cash Balance grew to $249.0 million in Q1 2025 per IMTX's latest filing, from $237.3 million in the prior quarter.
  • Over five years, Beginning Cash Balance peaked at $250.3 million in Q1 2021 and troughed at $149.3 million in Q1 2022.
  • A 4-year average of $221.5 million and a median of $243.2 million in 2024 frame the typical range for Beginning Cash Balance.
  • The sharpest annual moves came in 2021 and 2022: Beginning Cash Balance surged 119.4% in 2021, then tumbled 40.37% in 2022.
  • Over 4 years, Beginning Cash Balance stood at $250.3 million in 2021, then sank by 40.37% to $149.3 million in 2022, then surged by 59.01% to $237.3 million in 2024, then increased by 4.93% to $249.0 million in 2025.
  • According to Business Quant data, Beginning Cash Balance over the past three periods registered $249.0 million, $237.3 million, and $149.3 million for Q1 2025, Q1 2024, and Q1 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immatics 1.17 Bn 711.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 239.93 Mn
Dec 31, 2023 159.80 Mn
Dec 31, 2022 135.69 Mn
Sep 30, 2022 134.09 Mn
Jun 30, 2022 141.91 Mn
Mar 31, 2022 149.26 Mn
Dec 31, 2021 237.41 Mn
Sep 30, 2021 244.74 Mn
Jun 30, 2021 249.92 Mn
Mar 31, 2021 250.33 Mn
Dec 31, 2020 123.23 Mn
Sep 30, 2020 120.72 Mn
Jun 30, 2020 113.84 Mn
Mar 31, 2020 114.10 Mn
Dec 31, 2019 43.57 Mn
Sep 30, 2019 43.80 Mn
Jun 30, 2019 44.23 Mn